Tamarack Advisers, LP - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is and the CUSIP is G6674U908. A total of 3 filers reported holding NOVOCURE LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 3.0%.

Quarter-by-quarter ownership
Tamarack Advisers, LP ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2019$9,636,000
-57.0%
150,000
-77.6%
2.93%
-68.0%
Q4 2018$22,432,000
-32.9%
670,000
+5.5%
9.15%
-4.1%
Q3 2018$33,414,000
-3.0%
635,000
-42.3%
9.54%
-17.2%
Q2 2018$34,430,000
+61.6%
1,100,000
+4.3%
11.52%
-0.9%
Q4 2017$21,311,000
+44.4%
1,055,000
+41.9%
11.63%
+28.7%
Q3 2017$14,760,000
-5.7%
743,554
-17.8%
9.04%
-1.1%
Q2 2017$15,657,000
+95.1%
905,000
-8.7%
9.14%
+82.3%
Q1 2017$8,025,000
+23.9%
990,750
+20.1%
5.01%
+9.5%
Q4 2016$6,476,000825,0004.58%
Other shareholders
NOVOCURE LTD shareholders Q3 2017
NameSharesValueWeighting ↓
PURA VIDA INVESTMENTS, LLC 35,000$2,567,2500.13%
GROUP ONE TRADING, L.P. 301,800$22,137,0300.05%
JANE STREET GROUP, LLC 200,200$14,684,6700.01%
SIMPLEX TRADING, LLC 46,300$3,3960.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
JPMORGAN CHASE & CO 41,300$3,0290.00%
View complete list of NOVOCURE LTD shareholders